Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|December 6, 2008
Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control studySara Villeneuve, Laurent Orsi, Alain Monnereau, et al.
Ecancermedicalscience|October 21, 2020
Perspectives on cancer care in older patients in FranceMathilde Hauchecorne, Monica Pierro, Etienne Brain, et al.
Cancers|June 24, 2020
Triarylpyridine Compounds and Chloroquine Act in Concert to Trigger Lysosomal Membrane Permeabilization and Cell Death in Cancer CellsJennifer Beauvarlet, Rabindra Nath Das, Karla Alvarez-Valadez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2025
Machine Learning to Predict Mortality in Older Patients With Cancer: Development and External Validation of the Geriatric Cancer Scoring System Using Two Large French CohortsEtienne Audureau, Pierre Soubeyran, Claudia Martinez-Tapia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2022
A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve AnalysisAdolfo González Serrano, Marie Laurent, Thomas Barnay, et al.
Annals of Hematology|November 27, 2025
Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric studyRaphaël Maguet, Martin Eloit, Olivier Chinot, et al.
Clinics and Research in Hepatology and Gastroenterology|September 13, 2011
Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: a first-line phase II studyMarianne Fonck, Réné Brunet, Yves Becouarn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trialFranck Morschhauser, John Radford, Achiel Van Hoof, et al.
Pageof 12